Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_provenance.
- NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_assertion description "[We tested the hypothesis that levosimendan, an inodilator that acts through calcium sensitization, opening of ATP-dependent potassium channels and phosphodiesterase III inhibition, improves cardiac function and survival in double transgenic rats harboring human renin and angiotensinogen genes (dTGRs), a model of angiotensin II (Ang II)-induced hypertensive heart failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_provenance.
- NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_assertion evidence source_evidence_literature NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_provenance.
- NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_assertion SIO_000772 20811386 NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_provenance.
- NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_assertion wasDerivedFrom befree-20140225 NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_provenance.
- NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_assertion wasGeneratedBy ECO_0000203 NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP318196.RAfrizm1qokr316cVuuTGQdkK3K5QAQ-cFqS4-Pxvj7Wc130_provenance.